Mechanisms in photodynamic therapy: Part three - Photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction

Photodiagnosis and Photodynamic Therapy

Volumn 2, Issue 2, 2005, Pages 91-106

  Castano, Ana P ^a,b   Demidova, Tatiana N ^a,c   Hamblin, Michael R ^a,b,d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c TUFTS UNIVERSITY   (United States)

^d HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

Anti tumor immunity; Biodistribution; Cancer; Cellular destruction; Pharmacokinetics; Photodynamic therapy; Vascular shutdown

Indexed keywords

PHOTOSENSITIZING AGENT;

BLOOD FLOW; BLOOD VESSEL; CANCER RESEARCH; CELL DEATH; CLINICAL TRIAL; DRUG DISTRIBUTION; EXTRACELLULAR MATRIX; HUMAN; ILLUMINATION; LYMPH VESSEL; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REVIEW; TUMOR LOCALIZATION; TUMOR VOLUME;

EID: 23844473855     PISSN: 15721000     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1572-1000(05)00060-8     Document Type: Review

References (122)

1. A.P. Castano, T.N. Demidova, and M.R. Hamblin Mechanisms in photodynamic therapy: part one - photosensitizers, photochemistry and cellular localization Photodiagn Photodyn Ther 1 2004 279 293
2. A.P. Castano, T.N. Demidova, and M.R. Hamblin Mechanisms in photodynamic therapy: part two - cellular signaling, cell metabolism and modes of cell death Photodiagn Photodyn Ther 2 2005 1 23
3. E. Maugain, S. Sasnouski, V. Zorin, J.L. Merlin, F. Guillemin, and L. Bezdetnaya Foscan-based photodynamic treatment in vivo: correlation between efficacy and Foscan accumulation in tumor, plasma and leukocytes Oncol Rep 12 2004 639 645
4. D.A. Bellnier, W.R. Greco, J.C. Parsons, A.R. Oseroff, A. Kuebler, and T.J. Dougherty An assay for the quantitation of Photofrin in tissues and fluids Photochem Photobiol 66 1997 237 244
5. E.F. Gudgin Dickson, H. Holmes, and G. Jori On the source of the oscillations observed during in vivo zinc phthalocyanine fluorescence pharmacokinetic measurements in mice Photochem Photobiol 61 1995 506 509
6. H. Holmes, J.C. Kennedy, R. Pottier, R. Rossi, and G. Weagle A recipe for the preparation of a rodent food that eliminates chlorophyll-based tissue fluorescence J Photochem Photobiol B 29 1995 199
7. H. Cai, and C.K. Lim Comparison of HPLC, capillary electrophoretic and direct spectrofluorimetric methods for the determination of temoporfin- poly(ethylene glycol) conjugates in plasma Analyst 123 1998 2243 2245
8. F.M. Little, C.J. Gomer, S. Hyman, and M.L. Apuzzo Observations in studies of quantitative kinetics of tritium labelled hematoporphyrin derivatives (HpDI and HpDII) in the normal and neoplastic rat brain model J Neurooncol 2 1984 361 370
9. H.J. Jones, D.I. Vernon, and S.B. Brown Photodynamic therapy effect of m-THPC (Foscan) in vivo: correlation with pharmacokinetics Br J Cancer 89 2003 398 404
10. D.A. Bellnier, Y.K. Ho, R.K. Pandey, J.R. Missert, and T.J. Dougherty Distribution and elimination of Photofrin II in mice Photochem Photobiol 50 1989 221 228
11. J.J. Schuitmaker, R.I. Feitsma, J.G. Journee-De Korver, T.M. Dubbelman, and E.K. Pauwels Tissue distribution of bacteriochlorin a labelled with 99mTc-pertechnetate in hamster Greene melanoma Int J Radiat Biol 64 1993 451 458
12. J.K. Frisoli, E.G. Tudor, T.J. Flotte, T. Hasan, T.F. Deutsch, and K.T. Schomacker Pharmacokinetics of a fluorescent drug using laser-induced fluorescence Cancer Res 53 1993 5954 5961
13. C. Sheng, B.W. Pogue, E. Wang, J.E. Hutchins, and P.J. Hoopes Assessment of photosensitizer dosimetry and tissue damage assay for photodynamic therapy in advanced-stage tumors Photochem Photobiol 79 2004 520 525
14. D.A. Bellnier, and T.J. Dougherty A preliminary pharmacokinetic study of intravenous Photofrin in patients J Clin Laser Med Surg 14 1996 311 314
15. S.I. Moriwaki, J. Misawa, Y. Yoshinari, I. Yamada, M. Takigawa, and Y. Tokura Analysis of photosensitivity in Japanese cancer-bearing patients receiving photodynamic therapy with porfimer sodium (Photofrin) Photodermatol Photoimmunol. Photomed 17 2001 241 243
16. D.A. Bellnier, W.R. Greco, and G.M. Loewen Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients Cancer Res 63 2003 1806 1813
17. P.H. Brun, J.L. DeGroot, E.F. Dickson, M. Farahani, and R.H. Pottier Determination of the in vivo pharmacokinetics of palladium-bacteriopheophorbide (WST09) in EMT6 tumour-bearing Balb/c mice using graphite furnace atomic absorption spectroscopy Photochem Photobiol Sci 3 2004 1006 1010
18. M.J. Egorin, E.G. Zuhowski, D.L. Sentz, J.M. Dobson, P.S. Callery, and J.L. Eiseman Plasma pharmacokinetics and tissue distribution in CD2F1 mice of Pc4 (NSC 676418), a silicone phthalocyanine photodynamic sensitizing agent Cancer Chemother Pharmacol 44 1999 283 294
19. M.S. Ismail, C. Dressler, and P. Koeppe Pharmacokinetic analysis of octa-alpha-butyloxy-zinc phthalocyanine in mice bearing Lewis lung carcinoma J Clin Laser Med Surg 15 1997 157 161
20. M.M. Zuk, B.D. Rihter, M.E. Kenney, M.A. Rodgers, and M. Kreimer-Birnbaum Pharmacokinetic and tissue distribution studies of the photosensitizer bis(di-isobutyl octadecylsiloxy)silicon 2,3-naphthalocyanine (isoBOSINC) in normal and tumor-bearing rats Photochem Photobiol 59 1994 66 72
21. W.S. Chan, J.F. Marshall, R. Svensen, J. Bedwell, and I.R. Hart Effect of sulfonation on the cell and tissue distribution of the photosensitizer aluminum phthalocyanine Cancer Res 50 1990 4533 4538
22. K.W. Woodburn, S. Stylli, J.S. Hill, A.H. Kaye, J.A. Reiss, and D.R. Phillips Evaluation of tumour and tissue distribution of porphyrins for use in photodynamic therapy Br J Cancer 65 1992 321 328
23. M.G. Alvarez, F. Moran, and E.I. Yslas Pharmacokinetic and tumour-photosensitizing properties of methoxyphenyl porphyrin derivative Biomed Pharmacother 57 2003 163 168
24. A.M. Richter, S. Cerruti-Sola, E.D. Sternberg, D. Dolphin, and J.G. Levy Biodistribution of tritiated benzoporphyrin derivative (3H-BPD-MA), a new potent photosensitizer, in normal and tumor-bearing mice J Photochem Photobiol B 5 1990 231 244
25. R.W. Boyle, and D. Dolphin Structure and biodistribution relationships of photodynamic sensitizers Photochem Photobiol 64 1996 469 485
26. F.H. Figge, G.S. Weiland, and L.O. Manganiello Affinity of neoplastic, embryonic and traumatized tissues for porphyrins and metalloporphyrins Proc Soc Exp Biol Med 68 1948 640
27. M.R. Hamblin, and E.L. Newman On the mechanism of the tumour-localising effect in photodynamic therapy J Photochem Photobiol B 23 1994 3 8
28. C. Larroque, A. Pelegrin, and J.E. Van Lier Serum albumin as a vehicle for zinc phthalocyanine: photodynamic activities in solid tumour models Br J Cancer 74 1996 1886 1890
29. G. Jori In vivo transport and pharmacokinetic behavior of tumour photosensitizers Ciba Found Symp 146 1989 78 86
30. G. Jori, and E. Reddi The role of lipoproteins in the delivery of tumour-targeting photosensitizers Int J Biochem 25 1993 1369 1375
31. D. Kessel, A. Morgan, and G.M. Garbo Sites and efficacy of photodamage by tin etiopurpurin in vitro using different delivery systems Photochem Photobiol 54 1991 193 196
32. M. Kongshaug, J. Moan, and S.B. Brown The distribution of porphyrins with different tumour localising ability among human plasma proteins Br J Cancer 59 1989 184 188
33. J.C. Maziere, R. Santus, and P. Morliere Cellular uptake and photosensitizing properties of anticancer porphyrins in cell membranes and low and high density lipoproteins J Photochem Photobiol B 6 1990 61 68
34. M. Korbelik Low density lipoprotein receptor pathway in the delivery of Photofrin: how much is it relevant for selective accumulation of the photosensitizer in tumors? J Photochem Photobiol B 12 1992 107 109
35. F. Yuan, M. Leunig, D.A. Berk, and R.K. Jain Microvascular permeability of albumin, vascular surface area, and vascular volume measured in human adenocarcinoma LS174T using dorsal chamber in SCID mice Microvasc Res 45 1993 269 289
36. B.A. Allison, P.H. Pritchard, and J.G. Levy Evidence for low-density lipoprotein receptor-mediated uptake of benzoporphyrin derivative Br J Cancer 69 1994 833 839
37. W.G. Roberts, and T. Hasan Role of neovasculature and vascular permeability on the tumor retention of photodynamic agents Cancer Res 52 1992 924 930
38. M. Korbelik, and G. Krosl Photofrin accumulation in malignant and host cell populations of a murine fibrosarcoma Photochem Photobiol 62 1995 162 168
39. M. Korbelik, G. Krosl, and D.J. Chaplin Photofrin uptake by murine macrophages Cancer Res 51 1991 2251 2255
40. R. Pottier, and J.C. Kennedy The possible role of ionic species in selective biodistribution of photochemotherapeutic agents toward neoplastic tissue J Photochem Photobiol B 8 1990 1 16
41. I. Freitas Lipid accumulation: the common feature to photosensitizer- retaining normal and malignant tissues [news] J Photochem Photobiol B 7 1990 359 361
42. A. Graham, G. Li, and Y. Chen Structure-activity relationship of new octaethylporphyrin-based benzochlorins as photosensitizers for photodynamic therapy Photochem Photobiol 77 2003 561 566
43. G. Wendler, P. Lindemann, J.J. Lacapere, and V. Papadopoulos Protoporphyrin IX binding and transport by recombinant mouse PBR Biochem Biophys Res Commun 311 2003 847 852
44. T.J. Lampidis, S.D. Bernal, I.C. Summerhayes, and L.B. Chen Selective toxicity of rhodamine 123 in carcinoma cells in vitro Cancer Res 43 1983 716 720
45. D.J. Castro, R.E. Saxton, D.O. Rodgerson, Y.S. Fu, S.M. Bhuta, and H.R. Fetterman Rhodamine-123 as a new laser dye: in vivo study of dye effects on murine metabolism, histology and ultrastructure Laryngoscope 99 1989 1057 1062
46. E. Reddi Role of delivery vehicles for photosensitizers in the photodynamic therapy of tumours J Photochem Photobiol B 37 1997 189 195
47. K. Woodburn, E. Sykes, and D. Kessel Interactions of Solutol HS 15 and Cremophor EL with plasma lipoproteins Int J Biochem Cell Biol 27 1995 693 699
48. K. Woodburn, C.K. Chang, S. Lee, B. Henderson, and D. Kessel Biodistribution and PDT efficacy of a ketochlorin photosensitizer as a function of the delivery vehicle Photochem Photobiol 60 1994 154 159
49. F. Ginevra, S. Biffanti, A. Pagnan, R. Biolo, E. Reddi, and G. Jori Delivery of the tumour photosensitizer zinc(II)-phthalocyanine to serum proteins by different liposomes: studies in vitro and in vivo Cancer Lett 49 1990 59 65
50. F. Jiang, L. Lilge, B. Logie, Y. Li, and M. Chopp Photodynamic therapy of 9L gliosarcoma with liposome-delivered photofrin Photochem Photobiol 65 1997 701 706
51. A.M. Richter, E. Waterfield, A.K. Jain, A.J. Canaan, B.A. Allison, and J.G. Levy Liposomal delivery of a photosensitizer, benzoporphyrin derivative monoacid ring A (BPD), to tumor tissue in a mouse tumor model Photochem Photobiol 57 1993 1000 1006
52. L. Polo, A. Segalla, and G. Jori Liposome-delivered 131I-labelled Zn(II)-phthalocyanine as a radiodiagnostic agent for tumours Cancer Lett 109 1996 57 61
53. E. Allemann, J. Rousseau, N. Brasseur, S.V. Kudrevich, K. Lewis, and J.E. van Lier Photodynamic therapy of tumours with hexadecafluoro zinc phthalocyanine formulated in PEG-coated poly(lactic acid) nanoparticles Int J Cancer 66 1996 821 824
54. R. Margalit, and E. Silbiger Albumin microspheres as delivery systems for photodynamic drugs: physico-chemical studies and their implications for in vivo situations J Microencapsul 2 1985 183 196
55. A. Barel, G. Jori, A. Perin, P. Romandini, A. Pagnan, and S. Biffanti Role of high-, low- and very low-density lipoproteins in the transport and tumor-delivery of hematoporphyrin in vivo Cancer Lett 32 1986 145 150
56. P. Morliere, E. Kohen, and J.P. Reyftmann Photosensitization by porphyrins delivered to L cell fibroblasts by human serum low density lipoproteins. A microspectrofluorometric study Photochem Photobiol 46 1987 183 191
57. C.N. Zhou, C. Milanesi, and G. Jori An ultrastructural comparative evaluation of tumors photosensitized by porphyrins administered in aqueous solution, bound to liposomes or to lipoproteins Photochem Photobiol 48 1988 487 492
58. U. Schmidt-Erfurth, W. Bauman, and E. Gragoudas Photodynamic therapy of experimental choroidal melanoma using lipoprotein-delivered benzoporphyrin Ophthalmology 101 1994 89 99
59. R. Pani, R. Pellegrini, and M.N. Cinti New devices for imaging in nuclear medicine Cancer Biother Radiopharm 19 2004 121 128
60. A.K. Babbar, A.K. Singh, H.C. Goel, U.P. Chauhan, and R.K. Sharma Evaluation of (99m)Tc-labeled photosan-3, a hematoporphyrin derivative, as a potential radiopharmaceutical for tumor scintigraphy Nucl Med Biol 27 2000 587 592
61. E.M. Link, D.C. Costa, D. Lane, P.J. Blower, and M.F. Spittle Radioiodinated methylene blue for diagnosing early melanoma metastases Lancet 348 1996 753
62. E.M. Link, and R.N. Carpenter 211At-methylene blue for targeted radiotherapy of human melanoma xenografts: treatment of cutaneous tumors and lymph node metastases Cancer Res 52 1992 4385 4390
63. E.M. Link Targeting melanoma with 211At/131I-methylene blue: preclinical and clinical experience Hybridoma 18 1999 77 82
64. R.P. Evstigneeva, A.V. Zaitsev, V.N. Luzgina, V.A. Ol'Shevskaya, and A.A. Shtil Carboranylporphyrins for boron neutron capture therapy of cancer Curr Med Chem Anti-Cancer Agents 3 2003 383 392
65. J.S. Hill, S.B. Kahl, and A.H. Kaye Selective tumor uptake of a boronated porphyrin in an animal model of cerebral glioma Proc Natl Acad Sci USA 89 1992 1785 1789
66. M.A. Rosenthal, B. Kavar, and J.S. Hill Phase I and pharmacokinetic study of photodynamic therapy for high-grade gliomas using a novel boronated porphyrin J Clin Oncol 19 2001 519 524
67. L.J. Wilmes, M. Hoehn-Berlage, and T. Els In vivo relaxometry of three brain tumors in the rat: effect of Mn-TPPS, a tumor-selective contrast agent J Magn Reson Imaging 3 1993 5 12
68. K. Ikezaki, T. Nomura, M. Takahashi, B. Fritz-Zieroth, T. Inamura, and M. Fukui Selective and prolonged MRI enhancement by Mn-TPPS in an experimental rat brain tumour with peripheral benzodiazepine receptors Neurol Res 16 1994 393 397
69. M. Schaffer, B. Ertl-Wagner, and P.M. Schaffer The application of Photofrin II as a sensitizing agent for ionizing radiation - a new approach in tumor therapy? Curr Med Chem 12 2005 1209 1215
70. M. Schaffer, P.M. Schaffer, and L. Corti Photofrin as a specific radiosensitizing agent for tumors: studies in comparison to other porphyrins, in an experimental in vivo model J Photochem Photobiol B 66 2002 157 164
71. M. Schaffer, P.M. Schaffer, and M. Vogesser Application of Photofrin II as a specific radiosensitising agent in patients with bladder cancer - a report of two cases Photochem Photobiol Sci 1 2002 686 689
72. S.W. Young, F. Qing, and A. Harriman Gadolinium(III) texaphyrin: a tumor selective radiation sensitizer that is detectable by MRI Proc Natl Acad Sci USA 93 1996 6610 6615
73. S.W. Young, M.K. Sidhu, and F. Qing Preclinical evaluation of gadolinium (III) texaphyrin complex. A new paramagnetic contrast agent for magnetic resonance imaging Invest Radiol 29 1994 330 338
74. D. Magda, C. Lepp, and N. Gerasimchuk Redox cycling by motexafin gadolinium enhances cellular response to ionizing radiation by forming reactive oxygen species Int J Radiat Oncol Biol Phys 51 2001 1025 1036
75. R.A. Miller, K. Woodburn, Q. Fan, M.F. Renschler, J.L. Sessler, and J.A. Koutcher In vivo animal studies with gadolinium (III) texaphyrin as a radiation enhancer Int J Radiat Oncol Biol Phys 45 1999 981 989
76. A.M. Evens Motexafin gadolinium: a redox-active tumor selective agent for the treatment of cancer Curr Opin Oncol 16 2004 576 580
77. B.W. Henderson, S.M. Waldow, T.S. Mang, W.R. Potter, P.B. Malone, and T.J. Dougherty Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy Cancer Res 45 1985 572 576
78. W.S. Chan, N. Brasseur, C. La Madeleine, and J.E. van Lier Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin: tumor cell survival and blood flow Anticancer Res 16 1996 1887 1892
79. M. Korbelik, and G. Krosl Cellular levels of photosensitisers in tumours: the role of proximity to the blood supply Br J Cancer 70 1994 604 610
80. C.C. Lee, B.W. Pogue, and J.A. O'Hara Spatial heterogeneity and temporal kinetics of photosensitizer (AlPcS2) concentration in murine tumors RIF-1 and MTG-B Photochem Photobiol Sci 2 2003 145 150
81. X. Zhou, B.W. Pogue, B. Chen, and T. Hasan Analysis of effective molecular diffusion rates for verteporfin in subcutaneous versus orthotopic Dunning prostate tumors Photochem Photobiol 79 2004 323 331
82. C.J. Gomer, and N.J. Razum Acute skin response in albino mice following porphyrin photosensitization under oxic and anoxic conditions Photochem Photobiol 40 1984 435 439
83. T.H. Foster, R.S. Murant, R.G. Bryant, R.S. Knox, S.L. Gibson, and R. Hilf Oxygen consumption and diffusion effects in photodynamic therapy Radiat Res 126 1991 296 303
84. I. Georgakoudi, M.G. Nichols, and T.H. Foster The mechanism of Photofrin photobleaching and its consequences for photodynamic dosimetry Photochem Photobiol 65 1997 135 144
85. T. Xu, Y. Li, and X. Wu Application of lower fluence rate for less microvasculature damage and greater cell-killing during photodynamic therapy Lasers Med Sci 19 2004 150 154
86. T.M. Busch, E.P. Wileyto, and M.J. Emanuele Photodynamic therapy creates fluence rate-dependent gradients in the intratumoral spatial distribution of oxygen Cancer Res 62 2002 7273 7279
87. J.W. Snyder, W.R. Greco, D.A. Bellnier, L. Vaughan, and B.W. Henderson Photodynamic therapy: a means to enhanced drug delivery to tumors Cancer Res 63 2003 8126 8131
88. B.W. Henderson, T.M. Busch, and L.A. Vaughan Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during treatment, depending on fluence rate Cancer Res 60 2000 525 529
89. A. Curnow, J.C. Haller, and S.G. Bown Oxygen monitoring during 5-aminolaevulinic acid induced photodynamic therapy in normal rat colon. Comparison of continuous and fractionated light regimes J Photochem Photobiol B 58 2000 149 155
90. P. Babilas, V. Schacht, and G. Liebsch Effects of light fractionation and different fluence rates on photodynamic therapy with 5-aminolaevulinic acid in vivo Br J Cancer 88 2003 1462 1469
91. C. Abels Targeting of the vascular system of solid tumours by photodynamic therapy (PDT) Photochem Photobiol Sci 3 2004 765 771
92. W.M. Star, H.P. Marijnissen, A.E. van den Berg-Blok, J.A. Versteeg, K.A. Franken, and H.S. Reinhold Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers Cancer Res 46 1986 2532 2540
93. B.W. Henderson, and V.H. Fingar Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor Cancer Res 47 1987 3110 3114
94. V.H. Fingar, K.A. Siegel, T.J. Wieman, and K.W. Doak The effects of thromboxane inhibitors on the microvascular and tumor response to photodynamic therapy Photochem Photobiol 58 1993 393 399
95. V.H. Fingar, T.J. Wieman, P.S. Karavolos, K.W. Doak, R. Ouellet, and J.E. van Lier The effects of photodynamic therapy using differently substituted zinc phthalocyanines on vessel constriction, vessel leakage and tumor response Photochem Photobiol 58 1993 251 258
96. K.S. McMahon, T.J. Wieman, P.H. Moore, and V.H. Fingar Effects of photodynamic therapy using mono-l-aspartyl chlorin e6 on vessel constriction, vessel leakage, and tumor response Cancer Res 54 1994 5374 5379
97. M.J. Gilissen, L.E. van de Merbel-de Wit, W.M. Star, J.F. Koster, and W. Sluiter Effect of photodynamic therapy on the endothelium-dependent relaxation of isolated rat aortas Cancer Res 53 1993 2548 2552
98. V.H. Fingar, T.J. Wieman, and K.W. Doak Role of thromboxane and prostacyclin release on photodynamic therapy-induced tumor destruction Cancer Res 50 1990 2599 2603
99. M.R. Hamblin, M. Rajadhyaksha, T. Momma, N.S. Soukos, and T. Hasan In vivo fluorescence imaging of the transport of charged chlorin e6 conjugates in a rat orthotopic prostate tumour Br J Cancer 81 1999 261 268
100. K. Kurohane, A. Tominaga, K. Sato, J.R. North, Y. Namba, and N. Oku Photodynamic therapy targeted to tumor-induced angiogenic vessels Cancer Lett 167 2001 49 56
101. B. Chen, B.W. Pogue, and I.A. Goodwin Blood flow dynamics after photodynamic therapy with verteporfin in the RIF-1 tumor Radiat Res 160 2003 452 459
102. B. Chen, T. Roskams, and P.A. de Witte Antivascular tumor eradication by hypericin-mediated photodynamic therapy Photochem Photobiol 76 2002 509 513
103. A. Ferrario, D. Kessel, and C.J. Gomer Metabolic properties and photosensitizing responsiveness of mono-l-aspartyl chlorin e6 in a mouse tumor model Cancer Res 52 1992 2890 2893
104. P. Cramers, M. Ruevekamp, H. Oppelaar, O. Dalesio, P. Baas, and F.A. Stewart Foscan uptake and tissue distribution in relation to photodynamic efficacy Br J Cancer 88 2003 283 290
105. D.E. Dolmans, A. Kadambi, and J.S. Hill Targeting tumor vasculature and cancer cells in orthotopic breast tumor by fractionated photosensitizer dosing photodynamic therapy Cancer Res 62 2002 4289 4294
106. M. Korbelik, G. Krosl, J. Krosl, and G.J. Dougherty The role of host lymphoid populations in the response of mouse EMT6 tumor to photodynamic therapy Cancer Res 56 1996 5647 5652
107. M.L. Agarwal, H.E. Larkin, S.I. Zaidi, H. Mukhtar, and N.L. Oleinick Phospholipase activation triggers apoptosis in photosensitized mouse lymphoma cells Cancer Res 53 1993 5897 5902
108. N. Yamamoto, S. Homma, T.W. Sery, L.A. Donoso, and J.K. Hoober Photodynamic immunopotentiation: in vitro activation of macrophages by treatment of mouse peritoneal cells with haematoporphyrin derivative and light Eur J Cancer 27 1991 467 471
109. S. Herman, Y. Kalechman, U. Gafter, B. Sredni, and Z. Malik Photofrin II induces cytokine secretion by mouse spleen cells and human peripheral mononuclear cells Immunopharmacology 31 1996 195 204
110. S.O. Gollnick, X. Liu, B. Owczarczak, D.A. Musser, and B.W. Henderson Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo Cancer Res 57 1997 3904 3909
111. G. Krosl, M. Korbelik, and G.J. Dougherty Induction of immune cell infiltration into murine SCCVII tumour by photofrin-based photodynamic therapy Br J Cancer 71 1995 549 555
112. N. Yamamoto, S. Homma, and Y. Nakagawa Activation of mouse macrophages by in vivo and in vitro treatment with a cyanine dye, lumin J Photochem Photobiol B 13 1992 295 306
113. M. Korbelik, V.R. Naraparaju, and N. Yamamoto Macrophage-directed immunotherapy as adjuvant to photodynamic therapy of cancer Br J Cancer 75 1997 202 207
114. M. Korbelik Induction of tumor immunity by photodynamic therapy J Clin Laser Med Surg 14 1996 329 334
115. M. Korbelik, and G.J. Dougherty Photodynamic therapy-mediated immune response against subcutaneous mouse tumors Cancer Res 59 1999 1941 1946
116. G. Krosl, and M. Korbelik Potentiation of photodynamic therapy by immunotherapy: the effect of schizophyllan (SPG) Cancer Lett 84 1994 43 49
117. G. Krosl, M. Korbelik, J. Krosl, and G.J. Dougherty Potentiation of photodynamic therapy-elicited antitumor response by localized treatment with granulocyte-macrophage colony-stimulating factor Cancer Res 56 1996 3281 3286
118. M. Korbelik, and I. Cecic Enhancement of tumour response to photodynamic therapy by adjuvant mycobacterium cell-wall treatment J Photochem Photobiol B 44 1998 151 158
119. M. Korbelik, J. Sun, I. Cecic, and K. Serrano Adjuvant treatment for complement activation increases the effectiveness of photodynamic therapy of solid tumors Photochem Photobiol Sci 3 2004 812 816
120. A.P. Castano, Q. Liu, and M.R. Hamblin Photodynamic therapy cures green fluorescent protein expressing RIF1 tumors in mice Proc SPIE 5319 2004 50 59
121. A.P. Castano, and M.R. Hamblin Combination of photodynamic therapy and low-dose cyclophosphamide as a treatment for metastatic murine tumors Proc Am Assoc Cancer Res 45 2004 997
122. S.O. Gollnick, L. Vaughan, and B.W. Henderson Generation of effective antitumor vaccines using photodynamic therapy Cancer Res 62 2002 1604 1608